Averion International Corp. Signs Agreement With India CRO Apothecaries To Expand Core Oncology Competencies And Global Presence

Published: Jan 26, 2007

BOSTON--(BUSINESS WIRE)--Averion International Corp. (OTCBB:AVRO), a clinical research organization (CRO) specializing in oncology, medical devices, dermatology and nephrology, today announced that is has signed a non-exclusive agreement with Apothecaries Ltd. of New Delhi, India, a full-service CRO with a focus on oncology. Under the terms of the agreement, the two companies will jointly market and contract complementary services to biotechnology, pharmaceutical and medical device companies.

Back to news